WEKO3
アイテム
{"_buckets": {"deposit": "79492768-9bc6-409a-8cb8-97a6af3768d5"}, "_deposit": {"created_by": 1, "id": "73847", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "73847"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00073847", "sets": ["1"]}, "author_link": ["804171", "804159", "804167", "804161", "804172", "804173", "804158", "804164", "804165", "804168", "804175", "804156", "804162", "804166", "804169", "804174", "804157", "804170", "804163", "804160"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2018-06", "bibliographicIssueDateType": "Issued"}, "bibliographic_titles": [{"bibliographic_title": "Contrast Media \u0026 Molecular Imaging"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Introductions. [N-methyl-C-11]α-Methylaminoisobutyric acid (MeAIB) is an artificial amino acid radiotracer used for PET study, which is metabolically stable in vivo. In addition, MeAIB is transported by system A neutral amino acid transport, which is observed ubiquitously in all types of mammalian cells. It has already been shown that MeAIB-PET is useful for malignant lymphoma, head and neck cancers, and lung tumors. However, there have been no reports evaluating the usefulness of MeAIB-PET in the diagnosis of brain tumors. The purpose of this study is to investigate the efficacy of system A amino acid transport PET imaging, MeAIB-PET, in clinical brain tumor diagnosis compared to [S-methyl-C-11]-L-methionine (MET)-PET. Methods. Thirty-one consecutive patients (male: 16, female: 15), who were suspected of having brain tumors, received both MeAIB-PET and MET-PET within a 2-week interval. All patients were classified into two groups: Group A as a benign group, which included patients who were diagnosed as low-grade astrocytoma, grade II or less, or other low-grade astrocytoma (n=12) and Group B as a malignant group, which included patients who were diagnosed as anaplastic astrocytoma, glioblastoma multiforme (GBM), or recurrent GBM despite prior surgery or chemoradiotherapy (n=19). PET imaging was performed 20 min after the IV injection of MeAIB and MET, respectively. Semiquantitative analyses of MeAIB and MET uptake using SUVmax and tumor-to-contralateral normal brain tissue (T/N) ratio were evaluated to compare these PET images. ROC analyses for the diagnostic accuracy of MeAIB-PET and MET-PET were also calculated. Results. In MeAIB-PET imaging, the SUVmax was 1.20 ± 1.29 for the benign group and 2.94 ± 1.22 for the malignant group (p<0.005), and the T/N ratio was 3.77 ± 2.39 for the benign group and 16.83 ± 2.39 for the malignant group (p<0.005). In MET-PET, the SUVmax was 3.01 ± 0.94 for the benign group and 4.72 ± 1.61 for the malignant group (p<0.001), and the T/N ratio was 2.64 ± 1.40 for the benign group and 3.21 ± 1.14 for the malignant group (n.s.). For the analysis using the T/N ratio, there was a significant difference between the benign and malignant groups with MeAIB-PET with p<0.001. The result of ROC analysis using the T/N ratio indicated a better diagnosis accuracy for MeAIB-PET for brain tumors than MET-PET (p<0.001). Conclusions. MeAIB, a system A amino acid transport-specific radiolabeled agents, could provide better assessments for detecting malignant type brain tumors. In a differential diagnosis between low-grade and high-grade astrocytoma, MeAIB-PET is a useful diagnostic imaging tool, especially in evaluations using the T/N ratio. Clinical trial registration. This trial was registered with UMIN000032498.", "subitem_description_type": "Abstract"}]}, "item_8_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Hindawi"}]}, "item_8_relation_13": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "33026674", "subitem_relation_type_select": "PMID"}}]}, "item_8_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1155/2018/1292746. eCollection 2018.", "subitem_relation_type_select": "DOI"}}]}, "item_8_relation_17": {"attribute_name": "関連サイト", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1155/2018/1292746", "subitem_relation_type_select": "DOI"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1555-4309", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Nishii, Ryuichi"}], "nameIdentifiers": [{"nameIdentifier": "804156", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Higashi, Tatsuya"}], "nameIdentifiers": [{"nameIdentifier": "804157", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kagawa, Shinya"}], "nameIdentifiers": [{"nameIdentifier": "804158", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Arimoto, Maya"}], "nameIdentifiers": [{"nameIdentifier": "804159", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kishibe, Yoshihiko"}], "nameIdentifiers": [{"nameIdentifier": "804160", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Takahashi, Masaaki"}], "nameIdentifiers": [{"nameIdentifier": "804161", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamada, Shigeki"}], "nameIdentifiers": [{"nameIdentifier": "804162", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Saiki, Masaaki"}], "nameIdentifiers": [{"nameIdentifier": "804163", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Arakawa, Yoshiki"}], "nameIdentifiers": [{"nameIdentifier": "804164", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamauchi, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "804165", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okuyama, Chio"}], "nameIdentifiers": [{"nameIdentifier": "804166", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hojo, Masato"}], "nameIdentifiers": [{"nameIdentifier": "804167", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Munemitsu, Toshihiro"}], "nameIdentifiers": [{"nameIdentifier": "804168", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sawada, Masahiro"}], "nameIdentifiers": [{"nameIdentifier": "804169", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kobayashi, Masato"}], "nameIdentifiers": [{"nameIdentifier": "804170", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kawai, Keiichi"}], "nameIdentifiers": [{"nameIdentifier": "804171", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nagamachi, Shigeki"}], "nameIdentifiers": [{"nameIdentifier": "804172", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hirai, Toshinori"}], "nameIdentifiers": [{"nameIdentifier": "804173", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nishii, Ryuichi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "804174", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Higashi, Tatsuya", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "804175", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Differential Diagnosis between Low-Grade and High-Grade Astrocytoma Using System A Amino Acid Transport PET Imaging with C-11-MeAIB: A Comparison Study with C-11-Methionine PET Imaging", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Differential Diagnosis between Low-Grade and High-Grade Astrocytoma Using System A Amino Acid Transport PET Imaging with C-11-MeAIB: A Comparison Study with C-11-Methionine PET Imaging"}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/73847", "pubdate": {"attribute_name": "公開日", "attribute_value": "2018-10-30"}, "publish_date": "2018-10-30", "publish_status": "0", "recid": "73847", "relation": {}, "relation_version_is_last": true, "title": ["Differential Diagnosis between Low-Grade and High-Grade Astrocytoma Using System A Amino Acid Transport PET Imaging with C-11-MeAIB: A Comparison Study with C-11-Methionine PET Imaging"], "weko_shared_id": -1}
Differential Diagnosis between Low-Grade and High-Grade Astrocytoma Using System A Amino Acid Transport PET Imaging with C-11-MeAIB: A Comparison Study with C-11-Methionine PET Imaging
https://repo.qst.go.jp/records/73847
https://repo.qst.go.jp/records/73847d4e581eb-d49a-430a-b1a4-ce372e2007ab
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2018-10-30 | |||||
タイトル | ||||||
タイトル | Differential Diagnosis between Low-Grade and High-Grade Astrocytoma Using System A Amino Acid Transport PET Imaging with C-11-MeAIB: A Comparison Study with C-11-Methionine PET Imaging | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Nishii, Ryuichi
× Nishii, Ryuichi× Higashi, Tatsuya× Kagawa, Shinya× Arimoto, Maya× Kishibe, Yoshihiko× Takahashi, Masaaki× Yamada, Shigeki× Saiki, Masaaki× Arakawa, Yoshiki× Yamauchi, Hiroshi× Okuyama, Chio× Hojo, Masato× Munemitsu, Toshihiro× Sawada, Masahiro× Kobayashi, Masato× Kawai, Keiichi× Nagamachi, Shigeki× Hirai, Toshinori× Nishii, Ryuichi× Higashi, Tatsuya |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Introductions. [N-methyl-C-11]α-Methylaminoisobutyric acid (MeAIB) is an artificial amino acid radiotracer used for PET study, which is metabolically stable in vivo. In addition, MeAIB is transported by system A neutral amino acid transport, which is observed ubiquitously in all types of mammalian cells. It has already been shown that MeAIB-PET is useful for malignant lymphoma, head and neck cancers, and lung tumors. However, there have been no reports evaluating the usefulness of MeAIB-PET in the diagnosis of brain tumors. The purpose of this study is to investigate the efficacy of system A amino acid transport PET imaging, MeAIB-PET, in clinical brain tumor diagnosis compared to [S-methyl-C-11]-L-methionine (MET)-PET. Methods. Thirty-one consecutive patients (male: 16, female: 15), who were suspected of having brain tumors, received both MeAIB-PET and MET-PET within a 2-week interval. All patients were classified into two groups: Group A as a benign group, which included patients who were diagnosed as low-grade astrocytoma, grade II or less, or other low-grade astrocytoma (n=12) and Group B as a malignant group, which included patients who were diagnosed as anaplastic astrocytoma, glioblastoma multiforme (GBM), or recurrent GBM despite prior surgery or chemoradiotherapy (n=19). PET imaging was performed 20 min after the IV injection of MeAIB and MET, respectively. Semiquantitative analyses of MeAIB and MET uptake using SUVmax and tumor-to-contralateral normal brain tissue (T/N) ratio were evaluated to compare these PET images. ROC analyses for the diagnostic accuracy of MeAIB-PET and MET-PET were also calculated. Results. In MeAIB-PET imaging, the SUVmax was 1.20 ± 1.29 for the benign group and 2.94 ± 1.22 for the malignant group (p<0.005), and the T/N ratio was 3.77 ± 2.39 for the benign group and 16.83 ± 2.39 for the malignant group (p<0.005). In MET-PET, the SUVmax was 3.01 ± 0.94 for the benign group and 4.72 ± 1.61 for the malignant group (p<0.001), and the T/N ratio was 2.64 ± 1.40 for the benign group and 3.21 ± 1.14 for the malignant group (n.s.). For the analysis using the T/N ratio, there was a significant difference between the benign and malignant groups with MeAIB-PET with p<0.001. The result of ROC analysis using the T/N ratio indicated a better diagnosis accuracy for MeAIB-PET for brain tumors than MET-PET (p<0.001). Conclusions. MeAIB, a system A amino acid transport-specific radiolabeled agents, could provide better assessments for detecting malignant type brain tumors. In a differential diagnosis between low-grade and high-grade astrocytoma, MeAIB-PET is a useful diagnostic imaging tool, especially in evaluations using the T/N ratio. Clinical trial registration. This trial was registered with UMIN000032498. | |||||
書誌情報 |
Contrast Media & Molecular Imaging 発行日 2018-06 |
|||||
出版者 | ||||||
出版者 | Hindawi | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1555-4309 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 33026674 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1155/2018/1292746. eCollection 2018. | |||||
関連サイト | ||||||
識別子タイプ | DOI | |||||
関連識別子 | https://doi.org/10.1155/2018/1292746 |